Canopy Growth Corp

Canopy Growth Corp(CGC)の株式分析

$0.713

-0.022 (-3.06%)終値時点

Loading chart…
高値
0.756
始値
0.752
出来高加重平均価格
0.72
出来高
2.41M
時価総額
508.24M
安値
0.702
売買代金
1.74M
EV/EBITDA(TTM)
-6.00

Canopy Growth Corporation is a cannabis company, which produces, distributes, and sells a diverse range of cannabis and cannabis-related products for both adult-use and medical purposes. The Company brands include tweed, DOJA, LivRelief Infused, Deep Space, Ace Valley, 7ACRES, Vert, Twd, Wana, Hiway and Canopy Medical. The LivRelief Infused is transdermal creams contain a delivery system designed to penetrate a range of cannabidiol (CBD) and tetrahydrocannabinol (THC). The Deep Space offers beverages and gummies, containing the THC potency available in the Canadian market. The Ace Valley is a cannabis brand focused on ready-to-enjoy beverages. The 7ACRES offers products that are crafted by cannabis enthusiasts. The Wana gummies are created with a handcrafted recipe made with pectin, not gelatin, creating a gluten-free shelf-stable recipe that doesn’t melt. Its Canopy Medical is a pharmaceutical manufacturer for the production, import and release of medical cannabis products in Germany.

www.canopygrowth.com

AI分析 of Canopy Growth Corp (CGC)

売り

Canopy Growth Corp is not a good buy right now due to its current price of 0.713, a very low RSI of 17.94 indicating oversold conditions, and a troubling forward P/E of 20.37, which suggests high expectations despite ongoing losses.

バリュエーション指標

Canopy Growth Corp(CGC)の現在の予想PERは20.37で、5年平均は-1.24です。

予想PER

大幅な割高
5年平均 P/E
-1.24
現在のP/E
20.37
割高
8.72
割安
-11.20

予想EV/EBITDA

適正
5年平均 EV/EBITDA
-274.73
現在のEV/EBITDA
-6.00
割高
449.33
割安
-998.79

予想PSR

適正
5年平均 P/S
2.93
現在のP/S
0.87
割高
5.23
割安
0.64

Alphio AI による CGC の価格シナリオ

シナリオ価格は本年の最終月次予想レンジです。確率はモデルの固定ウェイト(25 / 50 / 25)であり、保証ではありません。

強

強気

強気 · 25%CGC

$1.78

シナリオ価格

基

基本

基本 · 50%CGC

$1.69

シナリオ価格

弱

弱気

弱気 · 25%CGC

$1.41

シナリオ価格

イベントタイムライン

2026-09-28 (ET)

08:00:00

Canopy Growth Appoints Sebastian Blote as Country Manager for Germany

08:00:00

Canopy Growth Appoints Sebastian Blote as Country Manager for Germany

2026-09-22 (ET)

08:00:00

Canopy Growth Supplies Medical Cannabis Flowers to the UK

2026-09-08 (ET)

08:00:00

Canopy Growth Expands Medical Cannabis Portfolio in Australia

2026-08-07 (ET)

07:30:00

Company Reports Q1 Revenue of C$100.4M

ニュース

CGC のよくある質問 — Alphio AI が回答

Canopy Growth Corporation is a cannabis company, which produces, distributes, and sells a diverse range of cannabis and cannabis-related products for both adult-use and medical purposes. The Company brands include tweed, DOJA, LivRelief Infused, Deep Space, Ace Valley, 7ACRES, Vert, Twd, Wana, Hiway and Canopy Medical. The LivRelief Infused is transdermal creams contain a delivery system designed to penetrate a range of cannabidiol (CBD) and tetrahydrocannabinol (THC). The Deep Space offers beverages and gummies, containing the THC potency available in the Canadian market. The Ace Valley is a cannabis brand focused on ready-to-enjoy beverages. The 7ACRES offers products that are crafted by cannabis enthusiasts. The Wana gummies are created with a handcrafted recipe made with pectin, not gelatin, creating a gluten-free shelf-stable recipe that doesn’t melt. Its Canopy Medical is a pharmaceutical manufacturer for the production, import and release of medical cannabis products in Germany. It operates in the Healthcare sector (MEDICINAL CHEMICALS & BOTANICAL PRODUCTS industry).

Canopy Growth Corp is not a good buy right now due to its current price of 0.713, a very low RSI of 17.94 indicating oversold conditions, and a troubling forward P/E of 20.37, which suggests high expectations despite ongoing losses.

コミュニティ

もっと見る ↗
0xSkewfalcon2026/9/27

As mid-term elections approach and marijuana legalization comes up for debate again, $CGC is a chart worth watching. A large triangle pattern is close to a breakout. If it can reclaim its 50 DMA, there could be upside ahead 📈🌿 $1+ looks fairly likely again in the near future.

もっと見る
登録またはログインして議論に参加

本ページは調査目的であり、投資助言ではありません。モデルは誤ることがあります。過去の実績は将来の成果を保証しません。

取引を始める